As assessed by 3H-thymidine uptake, both Hsp32-targeting drugs were found to inhibit the proliferation of Ph+ and Ph− ALL cells (primary cells and cell lines) after 48 hours of incubation (Figure 2C and Figure 2D). The gene discussed is HMOX1; the disease is acute lymphoblastic leukemia.